SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

63.66

163771.55

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.49

Back

maitri enterprises ltd

Sanofi India standalone net profit declines 7.54% in the September 2025 quarter

Oct 29,2025

Net profit of Sanofi India declined 7.54% to Rs 76.00 crore in the quarter ended September 2025 as against Rs 82.20 crore during the previous quarter ended September 2024. Sales declined 9.27% to Rs 475.40 crore in the quarter ended September 2025 as against Rs 524.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	475.40	524.00	-9
OPM %	28.23	22.84	-
PBDT	138.70	121.60	14
PBT	129.60	112.60	15
NP	76.00	82.20	-8

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)